|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 46 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$843,196 |
I/I |
35,078 |
5,093,345 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-28 |
4 |
B |
$25.04 |
$29,214 |
I/I |
1,164 |
139,730 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-28 |
4 |
B |
$25.04 |
$1,058,018 |
I/I |
42,156 |
5,135,501 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-01 |
4 |
B |
$25.54 |
$30,495 |
I/I |
1,193 |
140,923 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-01 |
4 |
B |
$25.54 |
$1,104,574 |
I/I |
43,212 |
5,178,713 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-02 |
4 |
B |
$26.00 |
$53,992 |
I/I |
2,069 |
142,992 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-02 |
4 |
B |
$26.00 |
$1,956,372 |
I/I |
74,969 |
5,253,682 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-04 |
4 |
B |
$25.44 |
$1,282,845 |
I/I |
50,400 |
5,304,082 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-04 |
4 |
B |
$25.44 |
$35,405 |
I/I |
1,391 |
144,383 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$7,430,585 |
I/I |
297,340 |
5,601,422 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-07 |
4 |
B |
$24.90 |
$205,095 |
I/I |
8,207 |
152,590 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-08 |
4 |
B |
$25.13 |
$45,887 |
I/I |
1,826 |
5,603,248 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-08 |
4 |
B |
$25.13 |
$1,256 |
I/I |
50 |
152,640 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-09 |
4 |
B |
$26.17 |
$1,333,262 |
I/I |
50,856 |
5,654,104 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-10 |
4 |
B |
$25.56 |
$511,150 |
I/I |
20,000 |
5,674,104 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-05-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(522,800) |
1,765,213 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-05-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(101,047) |
4,751 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$919 |
I/I |
34 |
194,218 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$39,581 |
I/I |
1,464 |
154,104 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$1,491,922 |
I/I |
55,183 |
5,729,287 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$934 |
I/I |
34 |
194,252 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$40,142 |
I/I |
1,461 |
155,565 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$1,512,235 |
I/I |
55,039 |
5,784,326 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,209 |
I/I |
44 |
194,296 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$46,894 |
I/I |
1,706 |
157,271 |
2.25 |
- |
|
1397 Records found
|
|
Page 46 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|